Brief: EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca
BRIEF-EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca Oct 16 (Reuters) - EMA's CHMP:
EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA
EMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR KYINSU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)